Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Art Therapy in Acute Schizophrenia [NA]
This entry notes that a clinical trial evaluating art therapy for acute schizophrenia conducted by Charite University in Berlin has complete…
-
CLINICAL_TRIALS trial_result · 2014-10-23Clinical Trial Update: Cognitive Behavioral Therapy for Patients With an Early Psychosis [Phase 2]
This Phase 2 clinical trial update reports the completion of a cognitive behavioral therapy program for patients with early psychosis, inclu…
-
FDA approval · 2014-10-21FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for SAPHRIS (asenapine maleate) from Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: The Effectiveness of FMPO in Improving the Quality of Care for Persons With Severe Mental Illness. [NA]
A completed clinical trial evaluated FMPO for improving quality of care in people with severe mental illness; results were posted in 2014 fo…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2) [NA]
Completed clinical trial EQUIP-2 evaluating collaborative care for schizophrenia; results posted in 2014.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-10Clinical Trial Update: Illness Management and Recovery for Veterans With Severe Mental Illness [NA]
Completed clinical trial on illness management and recovery for veterans with severe mental illness; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-10-09Clinical Trial Update: Predictors of Response to Cognitive Remediation in Schizophrenia [NA]
Completed VA-sponsored clinical trial in schizophrenia evaluating predictors of response to cognitive remediation; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: 20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165) [Phase 2]
Amgen's Phase 2 study evaluating AMG 747 for negative symptoms of schizophrenia was terminated.
-
FDA label_change · 2014-09-30FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental labeling application for CLOZARIL (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
FDA approval · 2014-09-30FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA INTRAMUSCULAR (olanzapine) by Eli Lilly and Company. The action results in changes t…
-
FDA approval · 2014-09-29FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental application for CLOZARIL (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
FDA approval · 2014-09-29FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for Abilify Maintena (aripiprazole) by Otsuka America Pharmaceutical, Inc., under NDA 202971.
-
FDA approval · 2014-09-29FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
The FDA approved a supplemental application for Versacloz (clozapine) submitted by TruPharma LLC.
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Cannabis and Schizophrenia: Self-Medication and Agonist Treatment [Phase 1]
Phase 1 clinical trial exploring cannabis use in schizophrenia for self-medication and agonist treatment; completed with results posted in 2…
-
FDA approval · 2014-09-26FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for risperidone (generic), enabling the marketed generic version to …
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: PEARL Schizophrenia Maintenance [Phase 3]
Phase 3 PEARL Schizophrenia Maintenance trial has completed and results have been posted. The study, sponsored by Sumitomo Pharma America, e…
-
FDA approval · 2014-09-25FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for risperidone from Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Risperdal Consta and Health Care Utilization in Patients With Schizophrenia [Phase 4]
Phase 4 clinical trial evaluating health care utilization in patients with schizophrenia treated with Risperdal Consta (risperidone long-act…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Theta Burst Transcranial Magnetic Stimulation as Treatment for Auditory Verbal Hallucinations [NA]
This clinical trial update reports on a completed study evaluating theta burst transcranial magnetic stimulation (TBS-TMS) for reducing audi…
-
FDA approval · 2014-09-25FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved a supplemental application for risperidone by Westminster Pharmaceuticals, LLC to support a generic version of risperidone.
-
CLINICAL_TRIALS trial_result · 2014-09-22Clinical Trial Update: Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence [Phase 4]
Phase 4 clinical trial evaluating the effects of Risperdal Consta in patients with schizophrenia or schizoaffective disorder who have incomp…
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate [Phase 3]
A Phase 3 clinical trial evaluating paliperidone palmitate for recently exacerbated schizophrenia has completed, providing an update on the …
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Phase IIb-III Study of BL-1020 Small Molecule for Schizophrenia [Phase 2, Phase 3]
Phase IIb/III study of BL-1020 for schizophrenia was terminated, with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia [Phase 3]
Phase 3 trial comparing intramuscular olanzapine to intramuscular haloperidol plus lorazepam for acute agitation in schizophrenia; study com…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning [Phase 4]
A Phase 4 clinical trial has completed evaluating the effects of aripiprazole and haloperidol on mesolimbic system functioning in patients w…